Stay updated on Napabucasin Combo in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Napabucasin Combo in Pancreatic Cancer Clinical Trial page.

Latest updates to the Napabucasin Combo in Pancreatic Cancer Clinical Trial page
- Check4 days agoChange DetectedLocation list updated: Taoyuan District, Taiwan, 333 was replaced with Taoyuan, Taiwan, 333, and a new Taoyuan, Taiwan site (333) was added.SummaryDifference0.0%

- Check11 days agoChange DetectedThe page shows a new revision tag of v3.5.3 replacing the previous v3.5.2, signaling a newer release of the page. This typically reflects minor release updates rather than substantive changes to the study data.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check48 days agoChange DetectedRevision: v3.5.0 added; Revision: v3.4.3 removed.SummaryDifference0.0%

- Check63 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This appears to be a minor version upgrade with no visible impact on study details.SummaryDifference0.0%

- Check85 days agoChange DetectedRevision tag updated from v3.4.1 to v3.4.2 on the page footer; no changes to study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Napabucasin Combo in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Napabucasin Combo in Pancreatic Cancer Clinical Trial page.